These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20670211)

  • 1. Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia.
    Bogason A; Masquelier M; Lafolie P; Skogastierna C; Paul C; Gruber A; Vitols S
    Drug Metab Lett; 2010 Dec; 4(4):228-32. PubMed ID: 20670211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia.
    Varatharajan S; Abraham A; Zhang W; Shaji RV; Ahmed R; Abraham A; George B; Srivastava A; Chandy M; Mathews V; Balasubramanian P
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1577-86. PubMed ID: 22562609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia.
    Varatharajan S; Panetta JC; Abraham A; Karathedath S; Mohanan E; Lakshmi KM; Arthur N; Srivastava VM; Nemani S; George B; Srivastava A; Mathews V; Balasubramanian P
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):1051-1058. PubMed ID: 27738808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and metabolism of daunorubicin by human leukemia cells.
    DeGregorio MW; Carrera CJ; Klock JC; Wilbur JR
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):29-32. PubMed ID: 6961971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells.
    Lautier D; Bailly JD; Demur C; Herbert JM; Bousquet C; Laurent G
    Int J Cancer; 1997 Apr; 71(2):292-9. PubMed ID: 9139856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia.
    Bogason A; Quartino AL; Lafolie P; Masquelier M; Karlsson MO; Paul C; Gruber A; Vitols S
    Br J Clin Pharmacol; 2011 Apr; 71(4):514-21. PubMed ID: 21204910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia.
    Tidefelt U; Liliemark J; Gruber A; Liliemark E; Sundman-Engberg B; Juliusson G; Stenke L; Elmhorn-Rosenborg A; Möllgård L; Lehman S; Xu D; Covelli A; Gustavsson B; Paul C
    J Clin Oncol; 2000 May; 18(9):1837-44. PubMed ID: 10784624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of mdr1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation.
    Xu D; Knaust E; Pisa P; Palucka K; Lundeberg J; Areström I; Peterson C; Gruber A
    Br J Haematol; 1996 Mar; 92(4):847-54. PubMed ID: 8616077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia.
    Qiu L; Zhou G; Cao S
    Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of daunorubicinol in the rabbit: comparison with daunorubicin.
    Maniez-Devos DM; Baurain R; Trouet A; Lesne M
    J Pharmacol; 1986; 17(1):14-20. PubMed ID: 3713197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo uptake of daunorubicin by acute myeloid leukemia (AML) cells measured by flow cytometry.
    Kokenberg E; Sonneveld P; Delwel R; Sizoo W; Hagenbeek A; Löwenberg B
    Leukemia; 1988 Aug; 2(8):511-7. PubMed ID: 3166077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia.
    Kokenberg E; Sonneveld P; Sizoo W; Hagenbeek A; Löwenberg B
    J Clin Oncol; 1988 May; 6(5):802-12. PubMed ID: 3163363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and sensitivity of daunorubicin in patients with acute leukemia.
    DeGregorio MW; Holleran WM; Macher BA; Linker CA; Wilbur JR
    Cancer Chemother Pharmacol; 1984; 13(3):230-4. PubMed ID: 6488444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.
    Londos-Gagliardi D; Baurain R; Robert J; Aubel-Sadron G
    Cancer Chemother Pharmacol; 1982; 9(1):45-8. PubMed ID: 6958392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.
    Takahashi RH; Bains OS; Pfeifer TA; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2008 Jun; 36(6):991-4. PubMed ID: 18322072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
    Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
    Leuk Res; 2003 Feb; 27(2):183-91. PubMed ID: 12526924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of intracellular uptake of daunorubicin in acute myeloid leukemia: a method analysis.
    Kokenberg E; Sonneveld P; Nooter K; van der Steuyt K; Löwenberg B
    Cancer Chemother Pharmacol; 1986; 17(1):63-8. PubMed ID: 3457648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.
    Bains OS; Karkling MJ; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2009 May; 37(5):1107-14. PubMed ID: 19204081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the sensitization of acute myeloid leukemia cell to daunorubicin by recombinant human interleukin-3].
    Wang J; Wang Q; Chen X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):30-2. PubMed ID: 11498841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.
    Galettis P; Boutagy J; Ma DD
    Br J Cancer; 1994 Aug; 70(2):324-9. PubMed ID: 7914424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.